Ambien CR 6.25 MG tablet 100S
Ended Awarded Last action
- Contract number
- SPE2DR26F23T4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,339
Award facts
- Contract value 100% obligated
- $2,338.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Ambien CR 6.25 mg tablets (100-count units) under a firm fixed-price contract valued at $2,338.65. The order, which was competitively awarded without set-aside designation, is scheduled for completion by December 3, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999.9 billion pharmaceutical supply vehicle that extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio of federal contracts covers a wide spectrum of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The DLA Troop Support Medical contract represents a strategic partnership enabling AmerisourceBergen to supply pharmaceutical commodities globally to support defense healthcare programs, with the Defense Logistics Agency planning to establish additional regional contracts under the Pharmaceutical Prime Vendor Global Program Generation V framework.
Quick answers
Who was awarded contract SPE2DR26F23T4?
SPE2DR26F23T4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F23T4 worth?
The government has obligated $2,339 on SPE2DR26F23T4.
Is contract SPE2DR26F23T4 an order under another contract?
Yes. SPE2DR26F23T4 is a delivery order under SPE2DR25D1047, an indefinite delivery contract.
Was contract SPE2DR26F23T4 competed?
The extent of competition for SPE2DR26F23T4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award